Literature DB >> 16060411

Fixed combination of manidipine and delapril in the treatment of mild to moderate essential hypertension: evaluation by 24-hour ambulatory blood pressure monitoring.

Amedeo Mugellini1, Alvaro Vaccarella, Aldo Celentano, Flavio Scanferla, Annalisa Zoppi, Roberto Fogari.   

Abstract

This present study assessed the antihypertensive efficacy of the fixed combination of manidipine and delapril by ambulatory blood pressure monitoring in patients with hypertension inadequately controlled by monotherapy with either component. After a 2-week placebo period, 55 mild to moderate hypertensive patients were randomized to manidipine 20 mg o.d. or delapril 30 mg b.i.d. for 4 weeks. After this period, 30 patients, aged 30-76 years (18 males and 12 females) whose diastolic blood pressure was not adequately controlled (> or = 90 mmHg) by monotherapy were treated with the fixed combination of manidipine 10 mg plus delapril 30 mg o.d. for 8 weeks. A 24-h ambulatory blood pressure monitoring recording was performed at the end of the placebo washout, of the monotherapy and of the combination therapy. Blood pressure control over the 24 h was quantified by the trough-to-peak ratio and the smoothness index. As compared to placebo, the fixed combination of manidipine and delapril produced a statistically significant (p<0.01) decrease in sitting clinic (18 +/- 9/14 +/- 5 mmHg) and 24-h blood pressure (12 +/- 7/10 +/- 5 mmHg) without affecting heart rate. This reduction was greater than that observed with single components. At the end of the 8-week combination treatment period, the rate of normalilized patients was 73%. Treatment with the fixed combination was associated with a positively high smoothness index (1.2 +/- 0.7/13.8 +/- 0.8) and with a relatively good trough-to-peak ratio (0.46/0.60). The combination of manidipine and delapril produced significant and smooth reductions in blood pressure values, which persisted over the 24-h dosing interval. These results support the use of fixed manidipine-delapril combination in the treatment of mild to moderate hypertensive patients inadequately controlled by monotherapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16060411     DOI: 10.1080/08038020510040621

Source DB:  PubMed          Journal:  Blood Press Suppl        ISSN: 0803-8023


  7 in total

Review 1.  Combination delapril/manidipine as antihypertensive therapy in high-risk patients.

Authors:  Roberto Fogari; Amedeo Mugellini; Maria Circelli; Giovanni Cremonesi
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

2.  Delapril/manidipine.

Authors:  Paul L McCormack; Gillian M Keating
Journal:  Drugs       Date:  2006       Impact factor: 9.546

3.  Effects of the fixed combination of manidipine plus delapril in the treatment of hypertension inadequately controlled by monotherapy with either component: a phase III, multicenter, open-label, clinical trial.

Authors:  Annalisa Zoppi; Amedeo Mugellini; Paola Preti; Andrea Rinaldi; Aldo Celentano; Emma Arezzi; Marco Alberici; Roberto Fogari
Journal:  Curr Ther Res Clin Exp       Date:  2003-07

Review 4.  Delapril plus indapamide: a review of the combination in the treatment of hypertension.

Authors:  Luca Cavalieri; Giovanni Cremonesi
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

5.  Fixed combination of lercanidipine and enalapril in the management of hypertension: focus on patient preference and adherence.

Authors:  Claudio Borghi; Francesca Santi
Journal:  Patient Prefer Adherence       Date:  2012-06-18       Impact factor: 2.711

Review 6.  Manidipine-delapril combination in the management of hypertension.

Authors:  Manuel Luque Otero
Journal:  Vasc Health Risk Manag       Date:  2007

Review 7.  Effective management of hypertension with dihydropyridine calcium channel blocker-based combination therapy in patients at high cardiovascular risk.

Authors:  H Haller
Journal:  Int J Clin Pract       Date:  2008-03-17       Impact factor: 2.503

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.